{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:29:52Z","timestamp":1787160592308,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":[":98020317"],"award-info":[{"award-number":[":98020317"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["B-9635"],"award-info":[{"award-number":["B-9635"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109999","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T18:12:38Z","timestamp":1678817558000},"page":"109999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["In silico design and in vivo evaluation of two multi-epitope vaccines containing build-in adjuvant with chitosan nanoparticles against uropathogenic Escherichia coli"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6811-2047","authenticated-orcid":false,"given":"Maryam","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Reza Asadi Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Ehsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abbasnezhad Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3134-9665","authenticated-orcid":false,"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109999_b0005","doi-asserted-by":"crossref","unstructured":"P. Loubet, et al., Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections, in: Front Microbiol. 2020. Pp. 1509.","DOI":"10.3389\/fmicb.2020.01509"},{"issue":"35","key":"10.1016\/j.intimp.2023.109999_b0010","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.vaccine.2019.07.031","article-title":"UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens","volume":"37","author":"Sarkissian","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0015","article-title":"Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections","volume":"4","author":"O'Brien","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"36","key":"10.1016\/j.intimp.2023.109999_b0020","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","article-title":"Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model","volume":"27","author":"Zhou","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2023.109999_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00010-12","article-title":"FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections","volume":"3","author":"Nesta","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.intimp.2023.109999_b0030","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","article-title":"UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies","volume":"8","author":"Terlizzi","year":"2017","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0035","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s41467-019-09814-6","article-title":"Unique structural features of a bacterial autotransporter adhesin suggest mechanisms for interaction with host macromolecules","volume":"10","author":"Paxman","year":"2019","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/j.intimp.2023.109999_b0040","doi-asserted-by":"crossref","first-page":"e1000586","DOI":"10.1371\/journal.ppat.1000586","article-title":"Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection","volume":"5","author":"Alteri","year":"2009","journal-title":"PLOS Pathogens"},{"issue":"8","key":"10.1016\/j.intimp.2023.109999_b0045","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/IAI.00174-10","article-title":"A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice","volume":"78","author":"Wieser","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2023.109999_b0050","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fmicb.2018.00783","article-title":"Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants","volume":"9","author":"Tan","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.intimp.2023.109999_b0055","doi-asserted-by":"crossref","unstructured":"D.J. Chen, et al., Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proceedings of the National Academy of Sciences, 107(7) (2010) 3099-3104.","DOI":"10.1073\/pnas.0805532107"},{"key":"10.1016\/j.intimp.2023.109999_b0060","doi-asserted-by":"crossref","first-page":"e6185","DOI":"10.7717\/peerj.6185","article-title":"Application of built-in adjuvants for epitope-based vaccines","volume":"6","author":"Lei","year":"2019","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.intimp.2023.109999_b0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/apm.12351","article-title":"Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles","volume":"123","author":"Srivastava","year":"2015","journal-title":"Apmis"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.109999_b0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(03)00377-6","article-title":"Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies","volume":"266","author":"Bivas-Benita","year":"2003","journal-title":"Int J Pharm"},{"issue":"sup1","key":"10.1016\/j.intimp.2023.109999_b0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/21691401.2017.1417868","article-title":"Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant","volume":"46","author":"Mehrabi","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"10.1016\/j.intimp.2023.109999_b0080","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.3892\/mmr.2015.3950","article-title":"Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine","volume":"12","author":"Gong","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.intimp.2023.109999_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.08.054","article-title":"Immunomodulatory properties of chitosan polymers","volume":"184","author":"Moran","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0090","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1080\/21691401.2019.1629948","article-title":"Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine","volume":"47","author":"Najminejad","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/21691401.2017.1290646","article-title":"Vibrio cholerae lipopolysaccharide loaded chitosan nanoparticle could save life by induction of specific immunoglobulin isotype","volume":"46","author":"Fasihi-Ramandi","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"10.1016\/j.intimp.2023.109999_b0100","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00109-006-0097-6","article-title":"Quantitative real-time RT-PCR data analysis: current concepts and the novel \u201cgene expression's CT difference\u201d formula","volume":"84","author":"Schefe","year":"2006","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"10.1016\/j.intimp.2023.109999_b0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"40","key":"10.1016\/j.intimp.2023.109999_b0110","doi-asserted-by":"crossref","first-page":"E8430","DOI":"10.1073\/pnas.1708125114","article-title":"IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases","volume":"114","author":"Hurdayal","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0115","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1038\/s41598-022-06414-1","article-title":"The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD\/CCL4-induced murine model of liver injury","volume":"12","author":"Raftar","year":"2022","journal-title":"Scientific Reports"},{"issue":"D1","key":"10.1016\/j.intimp.2023.109999_b0120","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.intimp.2023.109999_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105160","article-title":"Immunoinformatics design of a novel multi-epitope peptide vaccine to combat multi-drug resistant infections caused by Vibrio vulnificus","volume":"142","author":"Abbas","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.intimp.2023.109999_b0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1039\/C6MB00772D","article-title":"Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches","volume":"13","author":"Nezafat","year":"2017","journal-title":"Mol Biosyst"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0135","doi-asserted-by":"crossref","first-page":"13321","DOI":"10.1038\/s41598-019-49354-z","article-title":"Immunoinformatics approaches to explore Helicobacter Pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine","volume":"9","author":"Khan","year":"2019","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.intimp.2023.109999_b0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.12.36","article-title":"Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine","volume":"11","author":"Brumbaugh","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.intimp.2023.109999_b0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2019.02.007","article-title":"Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli","volume":"108","author":"Asadi Karam","year":"2019","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-022-00450-8","article-title":"An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission","volume":"7","author":"Tabynov","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.intimp.2023.109999_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.927306","article-title":"A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19","volume":"13","author":"Heidary","year":"2022","journal-title":"Front Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2023.109999_b0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2362.2008.02006.x","article-title":"Current concepts of molecular defence mechanisms operative during urinary tract infection","volume":"38","author":"Weichhart","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.intimp.2023.109999_b0165","series-title":"Clinical Management of Complicated Urinary Tract Infection","first-page":"Ch. 8.","article-title":"Urinary Tract Immunology","author":"Kelesidis","year":"2011"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2958.2008.06509.x","article-title":"Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection","volume":"71","author":"Hagan","year":"2009","journal-title":"Molecular microbiology"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/IAI.05322-11","article-title":"Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073","volume":"80","author":"Allsopp","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2023.109999_b0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"10.1016\/j.intimp.2023.109999_b0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.carbpol.2012.04.056","article-title":"N, N, N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV surface antigen","volume":"89","author":"Subbiah","year":"2012","journal-title":"Carbohydrate Polymers"},{"issue":"9\u201310","key":"10.1016\/j.intimp.2023.109999_b0190","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0264-410X(00)00309-1","article-title":"A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery","volume":"19","author":"McNeela","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.intimp.2023.109999_b0195","doi-asserted-by":"crossref","first-page":"e93761","DOI":"10.1371\/journal.pone.0093761","article-title":"Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge","volume":"9","author":"Mann","year":"2014","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.intimp.2023.109999_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftv026","article-title":"Protection against Helicobacter pylori infection in BALB\/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB","volume":"73","author":"Yang","year":"2015","journal-title":"Pathog Dis"},{"issue":"7","key":"10.1016\/j.intimp.2023.109999_b0205","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1080\/08820139.2022.2107931","article-title":"Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory","volume":"51","author":"Izeli Portilho","year":"2022","journal-title":"Immunol Invest"},{"issue":"1","key":"10.1016\/j.intimp.2023.109999_b0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13567-020-00762-4","article-title":"Intranasally administered protein coated chitosan nanoparticles encapsulating influenza H9N2 HA2 and M2e mRNA molecules elicit protective immunity against avian influenza viruses in chickens","volume":"51","author":"Hajam","year":"2020","journal-title":"Vet Res"},{"key":"10.1016\/j.intimp.2023.109999_b0215","author":"Hay","year":"2016","journal-title":"Health technology assessment"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2023.109999_b0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2362.2008.02005.x","article-title":"Innate and adaptive immune responses in the urinary tract","volume":"38","author":"Song","year":"2008","journal-title":"Eur J Clin Invest"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:55:59Z","timestamp":1778619359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692300320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":44,"alternative-id":["S156757692300320X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109999","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico design and in vivo evaluation of two multi-epitope vaccines containing build-in adjuvant with chitosan nanoparticles against uropathogenic Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109999"}}